| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kerstin Göbel, Susann Pankratz, Tilman Schneider-Hohendorf, Stefan Bittner, Michael K Schuhmann, Harald F Langer, Guido Stoll, Heinz Wiendl, Christoph Kleinschnitz, Sven G Meut. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. Journal of autoimmunity. vol 36. issue 2. 2011-07-22. PMID:21216565. |
we studied the expression of b1r and b2r and the effect of their inhibition on the disease course, bbb integrity and t cell migration following myelin oligodendrocyte glycoprotein (mog(35-55))-induced eae. |
2011-07-22 |
2023-08-12 |
mouse |
| Kristen A Rahn, Patricia J McLaughlin, Ian S Zago. Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis. Brain research. vol 1381. 2011-07-22. PMID:21256121. |
this study examined the long term effects of the opioid growth factor (ogf, [met(5)]-enkephalin) and a low dose of the opioid antagonist naltrexone (ldn) on expression of myelin oligodendrocyte glycoprotein (mog)-induced eae. |
2011-07-22 |
2023-08-12 |
mouse |
| Mir Sajad, Jamil Zargan, Raman Chawla, Sadiq Umar, Haider A Kha. Upregulation of CSPG3 accompanies neuronal progenitor proliferation and migration in EAE. Journal of molecular neuroscience : MN. vol 43. issue 3. 2011-07-21. PMID:21107918. |
eae was induced using myelin oligodendrocyte glycoprotein (mog) (35-55) which was characterized by massive polymorphonuclear cell infiltration and loss of myelin basic protein expression along with steep decrease of cnpase. |
2011-07-21 |
2023-08-12 |
Not clear |
| Hyun-Ja Ko, Jie-Yu Chung, Zeyad Nasa, James Chan, Christopher Siatskas, Ban-Hock Toh, Frank Alderucci. Targeting MOG expression to dendritic cells delays onset of experimental autoimmune disease. Autoimmunity. vol 44. issue 3. 2011-07-18. PMID:20883147. |
we have previously shown that retroviral transduction of bone marrow (bm) with vectors encoding the autoantigen, myelin oligodendrocyte glycoprotein (mog), can prevent the induction of experimental autoimmune encephalomyelitis (eae). |
2011-07-18 |
2023-08-12 |
mouse |
| Joanna Jung, Marek Michala. Cell surface targeting of myelin oligodendrocyte glycoprotein (MOG) in the absence of endoplasmic reticulum molecular chaperones. Biochimica et biophysica acta. vol 1813. issue 5. 2011-07-18. PMID:21172390. |
cell surface targeting of myelin oligodendrocyte glycoprotein (mog) in the absence of endoplasmic reticulum molecular chaperones. |
2011-07-18 |
2023-08-12 |
Not clear |
| Joanna Jung, Marek Michala. Cell surface targeting of myelin oligodendrocyte glycoprotein (MOG) in the absence of endoplasmic reticulum molecular chaperones. Biochimica et biophysica acta. vol 1813. issue 5. 2011-07-18. PMID:21172390. |
myelin oligodendrocyte glycoprotein (mog) is a type i integral membrane glycoprotein that localizes to myelin sheaths in the central nervous system. |
2011-07-18 |
2023-08-12 |
Not clear |
| Shin Ohtani, Kuniko Kohyama, Yoh Matsumot. Autoantibodies recognizing native MOG are closely associated with active demyelination but not with neuroinflammation in chronic EAE. Neuropathology : official journal of the Japanese Society of Neuropathology. vol 31. issue 2. 2011-07-11. PMID:20573031. |
for this purpose, we determined the titers of antibodies (ab) reacting with native myelin oligodendrocyte glycoprotein (mog)-expressing cells to evaluate the disease activity of chronic experimental autoimmune encephalomyelitis (eae) in rats and the relationship between anti-mogcme (cell membrane-expressed mog), ab titers and clinical and pathological parameters were evaluated. |
2011-07-11 |
2023-08-12 |
rat |
| Jessica L Williams, Aaron P Kithcart, Kristen M Smith, Todd Shawler, Gina M Cox, Caroline C Whitacr. Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis. Journal of neuroimmunology. vol 234. issue 1-2. 2011-07-11. PMID:21463904. |
memory cells specific for myelin oligodendrocyte glycoprotein (mog) govern the transfer of experimental autoimmune encephalomyelitis. |
2011-07-11 |
2023-08-12 |
Not clear |
| Jessica L Williams, Aaron P Kithcart, Kristen M Smith, Todd Shawler, Gina M Cox, Caroline C Whitacr. Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis. Journal of neuroimmunology. vol 234. issue 1-2. 2011-07-11. PMID:21463904. |
experimental autoimmune encephalomyelitis (eae) is induced by immunization with myelin antigens like myelin oligodendrocyte glycoprotein (mog). |
2011-07-11 |
2023-08-12 |
Not clear |
| Lihua Li, Hua Zhang, Michel Varrin-Doyer, Scott S Zamvil, A S Verkma. Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 25. issue 5. 2011-06-28. PMID:21257712. |
aquaporin-4 (aqp4) deficiency in mice reduces neuroinflammation in experimental autoimmune encephalomyelitis (eae) produced by active immunization with myelin oligodendrocyte glycoprotein peptide (mog). |
2011-06-28 |
2023-08-12 |
mouse |
| P H Lalive, M G Häusler, H Maurey, Y Mikaeloff, M Tardieu, H Wiendl, M Schroeter, H P Hartung, B C Kieseier, T Meng. Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Multiple sclerosis (Houndmills, Basingstoke, England). vol 17. issue 3. 2011-06-24. PMID:21177754. |
myelin oligodendrocyte glycoprotein (mog) may be implicated in the immunopathogenesis of multiple sclerosis (ms) inducing demyelination in the animal model of ms. |
2011-06-24 |
2023-08-12 |
Not clear |
| Rony Dahan, Moran Tabul, Yuan K Chou, Roberto Meza-Romero, Shayne Andrew, Adolph J Ferro, Gregory G Burrows, Halina Offner, Arthur A Vandenbark, Yoram Reite. TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes. European journal of immunology. vol 41. issue 5. 2011-06-24. PMID:21469129. |
rtl1000, which is composed of the β1α1 domains of human leukocyte antigen (hla)-dr2 linked to the encephalitogenic human myelin oligodendrocyte glycoprotein (mog)-35-55 peptide, was recently shown to be safe and well tolerated in a phase i clinical trial in ms. to evaluate the opposing biological effects of four- versus two-domain mhc-ii structures, we screened phage fab antibodies (abs) for the neutralizing activity of rtl1000. |
2011-06-24 |
2023-08-12 |
human |
| Rieko Muramatsu, Takekazu Kubo, Masahiro Mori, Yuka Nakamura, Yuki Fujita, Tsugio Akutsu, Tatsusada Okuno, Junko Taniguchi, Atsushi Kumanogoh, Mari Yoshida, Hideki Mochizuki, Satoshi Kuwabara, Toshihide Yamashit. RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis. Nature medicine. vol 17. issue 4. 2011-06-02. PMID:21423182. |
neutralizing antibodies to rgma attenuated clinical symptoms of mouse myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae) and reduced invasion of inflammatory cells into the cns. |
2011-06-02 |
2023-08-12 |
mouse |
| Silvia Piconese, Massimo Costanza, Silvia Musio, Claudio Tripodo, Pietro L Poliani, Giorgia Gri, Alessia Burocchi, Paola Pittoni, Andrea Gorzanelli, Mario P Colombo, Rosetta Pedott. Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice. Laboratory investigation; a journal of technical methods and pathology. vol 91. issue 4. 2011-06-01. PMID:21321538. |
surprisingly, we observed that myelin oligodendrocyte glycoprotein (mog)(35-55)-induced chronic eae was exacerbated in kit(w-sh/w-sh) compared with kit(+/+) mice. |
2011-06-01 |
2023-08-12 |
mouse |
| Sourojit Bhowmick, Robert B Clark, Stefan Brocke, Robert E Con. Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase. International immunology. vol 23. issue 2. 2011-05-26. PMID:21273399. |
here we show that an injection of encephalitogenic myelin oligodendrocyte glycoprotein (mog(35-55)) peptide into the anterior chamber of the eye (ac-mog), before the induction of or during established experimental autoimmune encephalomyelitis (eae) induced by mog(35-55), suppresses the induction or progression of eae, respectively. |
2011-05-26 |
2023-08-12 |
Not clear |
| Gregory F Wu, Kenneth S Shindler, Eric J Allenspach, Tom L Stephen, Hannah L Thomas, Robert J Mikesell, Anne H Cross, Terri M Laufe. Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity. Journal of autoimmunity. vol 36. issue 1. 2011-04-28. PMID:21095100. |
however, dcs alone were inefficient at promoting disease after immunization with the myelin protein myelin oligodendrocyte glycoprotein (mog), even in the presence of mhcii-deficient b cells. |
2011-04-28 |
2023-08-12 |
mouse |
| Helena S Domingues, Marsilius Mues, Hans Lassmann, Hartmut Wekerle, Gurumoorthy Krishnamoorth. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PloS one. vol 5. issue 11. 2011-04-27. PMID:21209700. |
in this report, we compare functional differences and pathogenic potential of "monoclonal" t cell lines that recognize myelin oligodendrocyte glycoprotein (mog) with the same transgenic tcr but are distinguished by an ifn-γ producing th1-like and il-17 producing th17-like cytokine signature. |
2011-04-27 |
2023-08-12 |
Not clear |
| Franziska Di Pauli, Simone Mader, Kevin Rostasy, Kathrin Schanda, Barbara Bajer-Kornek, Rainer Ehling, Florian Deisenhammer, Markus Reindl, Thomas Berge. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clinical immunology (Orlando, Fla.). vol 138. issue 3. 2011-04-14. PMID:21169067. |
recent studies demonstrated the presence of autoantibodies to native myelin oligodendrocyte glycoprotein (mog) in juvenile patients with acute disseminated encephalomyelitis (adem) and multiple sclerosis (ms). |
2011-04-14 |
2023-08-12 |
human |
| Peter Lackner, Bettina Kuenz, Markus Reindl, Maria Morandell, Thomas Berger, Erich Schmutzhard, Christian Egger. Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study. Journal of neuroinflammation. vol 7. 2011-04-12. PMID:21083890. |
this cross-sectional cohort study explores the potential role of antibodies to myelin oligodendrocyte glycoprotein (mog), a putative autoantigen in multiple sclerosis, in the pathogenesis of hand. |
2011-04-12 |
2023-08-12 |
Not clear |
| Luciana Berod, Christina Heinemann, Sylvia Heink, Angelika Escher, Christine Stadelmann, Sebastian Drube, Reinhard Wetzker, Johannes Norgauer, Thomas Kamrad. PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome. European journal of immunology. vol 41. issue 3. 2011-04-12. PMID:21287545. |
pi3kγ-deficient myelin oligodendrocyte glycoprotein (mog)(35-55) -specific cd4(+) t cells appeared later in the secondary lymphoid organs and in the cns than their wt counterparts. |
2011-04-12 |
2023-08-12 |
mouse |